Medclair AB (NGM:MCLR) Shiller PE Ratio: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:MCLR Medclair AB NGM:MCLR
71 GF Score
Price kr2.82
GF Value kr2.24
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Medclair AB Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Medclair AB  (NGM:MCLR) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Medclair AB Shiller PE Ratio Related Terms


Medclair AB Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Medclair AB's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medclair AB Shiller PE Ratio Chart

Medclair AB Annual Data
Trend Apr16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medclair AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NGM:MCLR vs ABT, SYK, MDT: Shiller PE Ratio Comparison

For the Medical Devices subindustry, Medclair AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medclair AB Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medclair AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medclair AB's Shiller PE Ratio falls into.


NGM:MCLR
71GF Score
Medclair AB NGM:MCLR
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medclair AB Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Medclair AB's E10 for the fiscal year that ended in Dec25 is calculated as:

For example, Medclair AB's adjusted earnings per share data for the fiscal year that ended in Dec25 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec25 (Change)*Current CPI (Dec25)
=0.06/133.3800*133.3800
=0.060

Current CPI (Dec25) = 133.3800.

Medclair AB Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201604 -0.320 100.732 -0.424
201712 -0.367 103.793 -0.472
201812 -0.233 105.912 -0.293
201912 -0.078 107.766 -0.097
202012 -0.024 108.296 -0.030
202112 -0.158 112.486 -0.187
202212 -0.060 126.365 -0.063
202312 -0.030 131.912 -0.030
202412 -0.010 132.987 -0.010
202512 0.060 133.380 0.060

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Medclair AB (NGM:MCLR) Overvalued in 2026?

Based on GuruFocus' analysis, Medclair AB stock appears to be overvalued. The current stock price of kr2.82 is trading 25.9% above its estimated GF Value™ of kr2.24. GuruFocus considers Medclair AB to be Modestly Overvalued.

Key valuation signals for NGM:MCLR:

  • Shiller PE Ratio:
  • GF Value™: kr2.24 vs. price of kr2.82 (25.9% above fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the NGM:MCLR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medclair AB Business Description

Address Fraktflygargatan 1, Stockholm, SWE, 128 30
Medclair AB is a Swedish medical technology company focused on reducing emissions of nitrous oxide (laughing gas) used for pain relief in healthcare. Its core products are nitrous oxide destruction units, including the Central Destruction Unit (CDU) for fixed installations and the Mobile Destruction Unit (MDU) for portable use, which catalytically decompose exhaled nitrous oxide into nitrogen and oxygen. The company also supplies complementary delivery and scavenging solutions such as double masks, single masks, mouthpieces, and free-flow systems, designed to protect healthcare professionals from occupational exposure. Its customers are primarily hospitals, maternity wards, dental clinics, and other healthcare providers in Sweden and other European markets. Revenue is generated mainly through sales of destruction units and related consumables, masks, and accessories, along with service, installation, and maintenance agreements. Medclair thus addresses both workplace safety and environmental concerns associated with nitrous oxide use.
71GF Score

Get the complete analysis for NGM:MCLR

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.82
Price
kr2.24
GF Value